Skip to main content

Table 3 Multivariate analysis shows that the risk score of the gene signature can be used as an independent prognostic factor

From: Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis

 

HR

HR.95L

HR.95H

pvalue

Age

1.031691

1.014011

1.04968

P < 0.001

Stage

1.193283

0.770596

1.847822

0.428359

T

1.20793

0.887669

1.643737

0.229414

N

1.30408

0.963671

1.764734

0.085395

riskScore

1.757823

1.430016

2.160774

P < 0.001

  1. T Tumor, N Lymph nodes
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us